PubRank

Peter B Jahrling

Author PubWeight™ 150.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 2005 6.77
2 Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002 6.59
3 Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 2003 6.35
4 Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003 4.67
5 Exotic emerging viral diseases: progress and challenges. Nat Med 2004 4.54
6 Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 2010 3.77
7 Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004 3.65
8 Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 2003 3.57
9 Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 2007 3.51
10 Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003 3.33
11 Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet 2006 3.15
12 Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 2003 2.82
13 Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2005 2.71
14 Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 2003 2.66
15 Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog 2007 2.64
16 Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. PLoS Med 2006 2.64
17 Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror 2011 2.62
18 Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis 2007 2.44
19 Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005 2.36
20 Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Virol 2002 2.31
21 Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002 2.26
22 Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J Infect Dis 2006 2.19
23 Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog 2010 2.18
24 Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog 2008 2.10
25 Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 2002 2.06
26 Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. J Virol 2011 1.99
27 The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci U S A 2004 1.85
28 CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nat Med 2011 1.83
29 Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms. J Clin Microbiol 2004 1.77
30 Framework for leadership and training of Biosafety Level 4 laboratory workers. Emerg Infect Dis 2008 1.66
31 Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol 2012 1.59
32 Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol 2004 1.55
33 Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis 2007 1.52
34 Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks. Am J Trop Med Hyg 2004 1.45
35 Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med 2006 1.40
36 MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis 2006 1.35
37 Real-time PCR assay to detect smallpox virus. J Clin Microbiol 2003 1.32
38 Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. PLoS One 2012 1.28
39 Clinical management of filovirus-infected patients. Viruses 2012 1.26
40 Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route. J Virol 2010 1.25
41 Clarification and guidance on the proper usage of virus and virus species names. Arch Virol 2010 1.20
42 Smallpox research activities: U.S. interagency collaboration, 2001. Emerg Infect Dis 2002 1.20
43 The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol 2007 1.20
44 Towards a vaccine against Ebola virus. Expert Rev Vaccines 2003 1.19
45 Viral hemorrhagic fevers. Clin Lab Med 2006 1.18
46 A proposal to change existing virus species names to non-Latinized binomials. Arch Virol 2010 1.18
47 Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol 2013 1.16
48 Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers. Emerg Infect Dis 2009 1.11
49 Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res 2011 1.11
50 Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol 2013 1.10
51 Taxonomic reorganization of the family Bornaviridae. Arch Virol 2014 1.09
52 Evaluation of monkeypox disease progression by molecular imaging. J Infect Dis 2011 1.07
53 Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease. Virology 2011 1.07
54 Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs. Virus Res 2003 1.05
55 Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus. J Med Virol 2002 1.01
56 Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry. J Virol 2011 1.01
57 Nyamiviridae: proposal for a new family in the order Mononegavirales. Arch Virol 2013 0.96
58 Interferon-beta 1a and SARS coronavirus replication. Emerg Infect Dis 2004 0.95
59 Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol 2013 0.94
60 Ebola and Marburg viruses: pathogenesis and development of countermeasures. Curr Mol Med 2005 0.93
61 Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog 2013 0.92
62 Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus. Mol Cell Proteomics 2011 0.92
63 A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence. Virology 2012 0.92
64 Inhibition of monkeypox virus replication by RNA interference. Virol J 2009 0.90
65 Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections. Virology 2002 0.90
66 Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox. Virology 2011 0.90
67 Progression of pathogenic events in cynomolgus macaques infected with variola virus. PLoS One 2011 0.87
68 Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein. Vaccine 2012 0.86
69 Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay. Virology 2002 0.85
70 The International Code of Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41. Arch Virol 2012 0.83
71 Genome Sequences of Simian Hemorrhagic Fever Virus Variant NIH LVR42-0/M6941 Isolates (Arteriviridae: Arterivirus). Genome Announc 2014 0.83
72 Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert Opin Drug Discov 2012 0.82
73 Lack of effect of lamivudine on Ebola virus replication. Emerg Infect Dis 2015 0.82
74 Intrabronchial inoculation of cynomolgus macaques with cowpox virus. J Gen Virol 2011 0.81
75 Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein. Immunogenetics 2005 0.81
76 Middle East respiratory syndrome: obstacles and prospects for vaccine development. Expert Rev Vaccines 2015 0.80
77 Molecular imaging of influenza and other emerging respiratory viral infections. J Infect Dis 2011 0.80
78 Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins. J Virol Methods 2011 0.79
79 Dynamics of oliveros virus infection in rodents in central Argentina. Vector Borne Zoonotic Dis 2007 0.79
80 The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PET. EJNMMI Res 2014 0.78
81 Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates. PLoS One 2013 0.78
82 Detection and identification of Variola virus in fixed human tissue after prolonged archival storage. Lab Invest 2004 0.78
83 Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus. J Virol 2013 0.77
84 Antiviral activity of the EB peptide against zoonotic poxviruses. Virol J 2012 0.77
85 The International Code of Virus Classification and Nomenclature (ICVCN): proposal for text changes for improved differentiation of viral taxa and viruses. Arch Virol 2013 0.75
86 Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions. PLoS One 2013 0.75
87 Generation and characterization of large-particle aerosols using a center flow tangential aerosol generator with a non-human-primate, head-only aerosol chamber. Inhal Toxicol 2015 0.75
88 Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone. Antiviral Res 2011 0.75
89 Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques. Virology 2013 0.75
90 Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID Integrated Research Facility-Frederick. Pathog Dis 2014 0.75